Inogen (INGN)
(Delayed Data from NSDQ)
$12.51 USD
+0.29 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $12.49 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.51 USD
+0.29 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $12.49 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Zacks News
Stryker (SYK) Beats Q3 Earnings, Misses Sales Estimates
by Zacks Equity Research
Stryker's (SYK) Q3 results benefit from solid segmental performance. Also, the company sustained strength in International sales.
Varian Medical (VAR) Jumps: Stock Rises 7.7%
by Zacks Equity Research
Varian Medical (VAR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Pick 5 Profitable Stocks With Alluring Net Income Ratio
by Zacks Equity Research
Investors always focus on companies that have a high level of profitability irrespective of the current market scenario.
McKesson (MCK) Beats Q2 Earnings, Misses Revenue Estimates
by Zacks Equity Research
McKesson's (MCK) Q2 results benefit from solid performance in the Medical-Surgical Solutions segment.
Varian (VAR) Misses Earnings, Beats Revenue Estimates in Q4
by Zacks Equity Research
Varian's (VAR) Q4 results benefit from strong growth in Oncology Systems. Also, solid guidance boosts investors' optimism.
Is Inogen (INGN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (INGN) Outperforming Other Medical Stocks This Year?
Medidata (MDSO) Tops Earnings & Revenue Estimates in Q3
by Zacks Equity Research
Strong performance in the Subscription revenues segment drives Medidata???s (MDSO) results in Q3. Professional services also posted steady growth.
Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues
by Zacks Equity Research
Strong performance in the Instruments & Accessories and Systems segments drive Intuitive Surgical's (ISRG) top line in Q3.
Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed
by Zacks Equity Research
Within Structural Heart, growth was driven by several product areas across Abbott's (ABT) broad portfolio, including AMPLATZER PFO Occluder and MitraClip.
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
by Zacks Equity Research
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
Bet On 5 Stock Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Baxter & ASPEN Launch PN Tools to Boost Clinical Nutrition
by Zacks Equity Research
Baxter (BAX) and ASPEN's SmartPN lends the company a competitive edge in the MedTech space.
Medidata Cloud Manages Echocardiogram Images in WASE Study
by Zacks Equity Research
Medidata's (MDSO) Rave Imaging platform is a cloud-based clinical data management system used to electronically capture, manage and report clinical research data.
Here's Why You Should Hold CONMED Stock in Your Portfolio
by Zacks Equity Research
Despite aggressive rivalry in the MedTech space, CONMED (CNMD) to gain from its unique offerings and an extensive product portfolio.
Here's Why You Should Buy HealthEquity (HQY) Stock Right Now
by Zacks Equity Research
Strong presence in the HSA space and a solid guidance for fiscal 2019 make HealthEquity (HQY) a promising investment pick.
Can Inogen (INGN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Inogen (INGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Walgreens (WBA) Q4 Earnings Gain From Overall Strength?
by Zacks Equity Research
Several planned developments, early benefits of new pharmacy contracts as well as an increase in volume are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.
Is Inogen (INGN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (INGN) Outperforming Other Medical Stocks This Year?
Stryker's HyperBranch Buyout to Boost Neurotechnology Business
by Zacks Equity Research
Stryker's (SYK) craniomaxillofacial division's market prospects bright.
Here's Why You Should Buy Inogen (INGN) Stock Right Now
by Zacks Equity Research
Inogen (INGN) is expected to gain from strong international foothold and a raised view for 2018.
Zacks.com highlights: Illumina, Weight Watchers International, Inogen, Caterpillar and QUALCOMM
by Zacks Equity Research
Zacks.com highlights: Illumina, Weight Watchers International, Inogen, Caterpillar and QUALCOMM
Looking for Earnings Beat? Play These Top 5 Stocks
by Sanghamitra Saha
These top-ranked stocks may surpass bottom-line estimates in their next release.
Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DWAS
Inogen (INGN) Up 14.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inogen (INGN) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Inogen (INGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.